Provided by Tiger Trade Technology Pte. Ltd.

Cytosorbents

0.6700
-0.0010-0.15%
Volume:19.76K
Turnover:13.36K
Market Cap:42.08M
PE:-3.72
High:0.6850
Open:0.6800
Low:0.6700
Close:0.6710
52wk High:1.61
52wk Low:0.6000
Shares:62.80M
Float Shares:54.98M
Volume Ratio:0.26
T/O Rate:0.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1800
EPS(LYR):-0.3806
ROE:-93.26%
ROA:-19.01%
PB:4.67
PE(LYR):-1.76

Loading ...

Cytosorbents Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Jan 12

BRIEF-CytoSorbents FY Revenue USD 37 Million

Reuters
·
Jan 12

Cytosorbents FY Revenue USD 37 Million

THOMSON REUTERS
·
Jan 12

Cytosorbents Corp - Drugsorb-Atr FDA Meeting Scheduled, Decision Expected Mid-2026

THOMSON REUTERS
·
Jan 12

Cytosorbents FY Product Gross Margin 72%

THOMSON REUTERS
·
Jan 12

Press Release: CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update

Dow Jones
·
Jan 12

Cytosorbents Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Dec 17, 2025

CytoSorbents Corporation Leadership Joins D. Boral Capital for Virtual Fireside Chat

Reuters
·
Dec 10, 2025

CytoSorbents CEO Phillip P. Chan Reports Acquisition of Common Shares

Reuters
·
Nov 21, 2025

CytoSorbents Q3 Revenue USD 9.485 Million

Reuters
·
Nov 20, 2025

CytoSorbents Corporation to Present at Jefferies Global Healthcare Conference

Reuters
·
Nov 18, 2025

CytoSorbents Corporation reports Q3 2025 revenue of $9.5 million

Reuters
·
Nov 15, 2025

Cytosorbents Corp’s Earnings Call: Growth Amid Challenges

TIPRANKS
·
Nov 15, 2025

Cytosorbents Is Maintained at Neutral by HC Wainwright & Co.

Dow Jones
·
Nov 14, 2025

CytoSorbents Reports Third Quarter 2025 Revenue of $9.5 Million

Reuters
·
Nov 14, 2025

Blood purification firm CytoSorbents Q3 revenue misses estimates

Reuters
·
Nov 14, 2025

CytoSorbents Q3 Revenue USD 9.485 Million

Reuters
·
Nov 14, 2025

CytoSorbents Reports 10% Revenue Growth and Improved Gross Margins in Q3 2025

Reuters
·
Nov 14, 2025

Cytosorbents Corp: Reduced Its Workforce by Approximately 10%

THOMSON REUTERS
·
Nov 14, 2025

Cytosorbents Corp: Expects to Reach Operating Cash Flow Break-Even in Q1 of 2026

THOMSON REUTERS
·
Nov 14, 2025